Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220009553 220003898 1.6 68 Curative (C) 2018-12-01 2018-12-01 CYCLOPHOSPHAMIDE + FLUDARABINE 02 N 220020151 FLUDARABINE + MELPHALAN
220009554 220003899 null 87.3 null null 2015-08-02 Dacarbazine null null 220020309 LENALIDOMIDE
220009555 220003900 1.53 null null 2017-09-10 2017-09-10 Triple / Double Intrathecal Therapy 2 N 220020342 CYTARABINE + FLUDARABINE
220009556 220003901 1.63 75.5 Palliative (P) 2016-06-18 2016-06-18 Alemtuzumab cond (RI ALLO CAMP100) Y N 220020350 FCIST
220009557 220012087 1.57 74 Curative (C) 2013-12-23 2013-12-23 IDARUBICIN + MITOXANTRONE + Tretinoin N N 220020384 FLA
220009558 220012087 1.66 null Curative (C) 2017-06-13 2017-06-18 Cyclophosphamide+Fludara+TBI Allo Y N 220020384 ARSENIC TRIOXIDE + TRETINOIN
220009559 220012087 1.77 null Curative (C) null 2018-02-20 CAPECITABINE + MITOMYCIN + RT N Y 220020384 ALEMTUZUMAB + CYCLO + FLUDARABINE
220009560 220003902 1.75 78 Curative (C) 2014-12-29 2014-12-29 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE 02 N 220020531 CYCLOPHOSPHAMIDE + FLUDARABINE + THIOTEPA
220009561 220012088 1.8 12.8 Curative (C) 2016-09-10 2016-09-10 Fludarabine + Melphalan RIC Allo 2 N 220020546 BUSULFAN + FLUDARABINE + METHOTREXATE
220009562 220012088 1.95 null null 2016-02-13 2016-02-19 LENALIDOMIDE 99 N 220020546 FCIST
220009563 220012088 1.67 48 Adjuvant (A) 2014-10-12 2014-10-31 Carboplatin + Docetaxel 02 null 220020546 CARBOPLATIN + RT
220009564 220012088 1.73 87 Palliative (P) 2013-06-13 2013-06-13 Cisplatin + Docetaxel +Fluorouracil 2 null 220020546 CHOP R
220009565 220003903 1.69 46.7 Curative (C) 2014-03-13 2014-03-13 CARBOPLATIN + EPIRUBICIN N Y 220020925 BEP
220009566 220003903 1.58 null Curative (C) 2016-01-19 2016-02-02 Capecitabine N N 220020925 FLUDARABINE + MELPHALAN
220009567 220003903 1.65 42.3 Palliative (P) 2018-07-23 2018-07-23 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220020925 IPILIMUMAB
220009568 220003904 1.81 0 Curative (C) 2015-10-28 2015-10-28 Enzalutamide 02 N 220020946 TRASTUZUMAB
220009569 220003905 0 0 Palliative (P) 2013-04-27 2013-05-06 GEMTUZUMAB OZOGAMICIN 02 null 220020972 CISPLATIN + PEMETREXED
220009570 220003906 null null Curative (C) 2015-02-04 2015-02-04 Cisplatin + Pemetrexed N N 220020987 FLUDARABINE + MELPHALAN
220009571 220012090 null null null 2018-09-07 2018-09-07 Arsenic trioxide N N 220021062 ECF
220009572 220003907 1.71 null Curative (C) 2014-12-20 2014-12-20 Pazopanib N N 220021070 IVAC
220009573 220003908 null 0 Not known (9) 2013-07-07 2013-07-09 Methotrexate intrathecal 02 N 220021091 FEC + DOCETAXEL
220009574 220003908 1.62 null null 2018-09-26 2018-09-27 EC N N 220021091 CAPECITABINE
220009575 220003909 0.62 78.1 null 2013-02-17 2013-06-21 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN N N 220021197 CAPECITABINE
220009576 220003910 1.56 66.1 Palliative (P) 2017-01-30 2017-02-14 Busulfan Oral 02 null 220021277 CISPLATIN + PEMETREXED
220009577 220012092 null 87.2 null 2017-08-17 2017-08-20 VINCRISTINE 02 Y 220021328 RUXOLITINIB
220009578 220012092 1.81 120 Curative (C) 2016-10-22 2016-10-23 FIGARO TRIAL 02 N 220021328 TRIPLE INTRATHECAL
220009579 220003911 1.69 83.4 Curative (C) 2016-02-08 2016-04-11 CAPECITABINE + TEMOZOLOMIDE 02 null 220021452 CYTARABINE + DAUNORUBICIN + ETOPOSIDE
220009580 220003912 1.69 85.1 Curative (C) null 2014-12-01 Carboplatin + Docetaxel N N 220021486 BOSUTINIB
220009581 220003913 1.69 null null 2017-11-24 2017-11-24 Fludarabine + Melphalan RIC Allo N null 220021563 ROMAZA TRIAL
220009582 220012093 1.58 0 Not known (9) 2015-04-27 2015-05-07 ATG + Busulfan + Fludarabine 02 N 220021593 CISPLATIN + DOCETAXEL + FLUOROURACIL
220009583 220012093 0 74.2 Curative (C) 2015-11-26 2015-11-26 CARBOPLATIN + RT N N 220021593 BEP
220009584 220003914 1.85 90 Curative (C) 2017-04-14 2017-04-14 IDARUBICIN + MITOXANTRONE + Tretinoin 2 N 220021657 UKALL2011
220009585 220012094 1.86 75 Curative (C) null 2014-04-12 ALL UKALL2011 TRIAL N N 220021712 CLOFARABINE + CYTARABINE
220009586 220012094 null 87.3 Palliative (P) 2014-02-17 2014-02-18 Cyclophosphamide TBI Allograft 02 N 220021712 LI-1 TRIAL
220009587 220019091 1.54 94.1 Curative (C) 2015-11-29 2015-12-20 ATG + Busulfan + Fludarabine N N 220021845 CHOP R
220009588 220003915 null null null 2017-03-02 2017-03-02 Cyclophosphamide + Etoposide (PO) null null 220021848 TRASTUZUMAB
220009589 220003916 1.68 102.4 Curative (C) 2017-10-03 2017-10-17 Dacarbazine 02 N 220021870 FIGARO TRIAL
220009590 220003916 1.89 70.7 null 2019-03-02 2019-03-25 Methotrexate Intrathecal (any age) N N 220021870 CYTARABINE INTRATHECAL
220009591 220003917 1.77 null Curative (C) null 2017-05-05 CHOP R - 21 days null null 220021916 FLUDARABINE + MELPHALAN
220009592 220003918 null -1 Disease modification (D) 2018-12-11 2018-12-17 Capecitabine N N 220022111 LENALIDOMIDE
220009593 220003918 1.62 16.8 null 2016-11-28 2016-12-15 CHLORAMBUCIL + OBINUTUZUMAB N N 220022111 METHOTREXATE INTRATHECAL
220009594 220003918 1.71 64.9 null 2014-03-09 2014-04-07 Mercaptopurine 2 N 220022111 LANREOTIDE
220009595 220003919 null 76.15 Curative (C) 2017-08-19 2017-08-28 CABOZANTINIB 2 N 220022434 CLOFARABINE + CYTARABINE
220009596 220003919 0 65 Disease modification (D) 2017-12-01 2017-12-01 CVP R 02 N 220022434 MELPHALAN
220009597 220003920 null 84.4 null 2019-03-10 2019-03-21 CYTARABINE + Hydrocortisone + Hydrocortisone + METHOTREXATE Y null 220022614 ANAGRELIDE
220009598 220003921 1.58 40.9 Not known (9) 2015-09-16 2015-09-23 BUSULFAN N N 220022648 OCTREOTIDE
220009599 220003922 1.95 null Curative (C) 2018-06-14 2018-06-15 Ipilimumab N N 220022721 CISPLATIN
220009600 220003923 null 81.4 null 2017-05-19 2017-05-27 Cisplatin + Docetaxel +Fluorouracil 02 N 220022723 FLUOROURACIL
220009601 220003924 1.73 85.1 Curative (C) null 2017-11-12 ALL UKALL60+ TRIAL null null 220022769 CYCLOPHOSPHAMIDE
220009602 220003925 1.48 74.8 null 2014-09-13 2014-09-16 RUXOLITINIB null N 220022881 CISPLATIN